Global Famciclovir Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Famciclovir market report explains the definition, types, applications, major countries, and major players of the Famciclovir market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Mylan

    • Apotex

    • HETERO

    • Novartis

    • Beijing Jialin Pharmaceutical

    • Aurobindo Pharma

    • Hainan choitec Pharmaceuticals

    • Cipla

    • Chengdu Diao Pharmaceutical Group

    • Shandong Luoxin Pharmaceutical Group

    • Hikma

    • Teva

    • Macleods Pharmaceuticals

    • HISUN

    By Type:

    • 125 mg Tablets

    • 250 mg Tablets

    • 500 mg Tablets

    By End-User:

    • Cold sores

    • Genital herpes

    • Shingles

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Famciclovir Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Famciclovir Outlook to 2028- Original Forecasts

    • 2.2 Famciclovir Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Famciclovir Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Famciclovir Market- Recent Developments

    • 6.1 Famciclovir Market News and Developments

    • 6.2 Famciclovir Market Deals Landscape

    7 Famciclovir Raw Materials and Cost Structure Analysis

    • 7.1 Famciclovir Key Raw Materials

    • 7.2 Famciclovir Price Trend of Key Raw Materials

    • 7.3 Famciclovir Key Suppliers of Raw Materials

    • 7.4 Famciclovir Market Concentration Rate of Raw Materials

    • 7.5 Famciclovir Cost Structure Analysis

      • 7.5.1 Famciclovir Raw Materials Analysis

      • 7.5.2 Famciclovir Labor Cost Analysis

      • 7.5.3 Famciclovir Manufacturing Expenses Analysis

    8 Global Famciclovir Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Famciclovir Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Famciclovir Export by Region (Top 10 Countries) (2017-2028)

    9 Global Famciclovir Market Outlook by Types and Applications to 2022

    • 9.1 Global Famciclovir Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 125 mg Tablets Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 250 mg Tablets Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global 500 mg Tablets Consumption and Growth Rate (2017-2022)

    • 9.2 Global Famciclovir Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cold sores Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Genital herpes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Shingles Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Famciclovir Market Analysis and Outlook till 2022

    • 10.1 Global Famciclovir Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Famciclovir Consumption (2017-2022)

      • 10.2.2 Canada Famciclovir Consumption (2017-2022)

      • 10.2.3 Mexico Famciclovir Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Famciclovir Consumption (2017-2022)

      • 10.3.2 UK Famciclovir Consumption (2017-2022)

      • 10.3.3 Spain Famciclovir Consumption (2017-2022)

      • 10.3.4 Belgium Famciclovir Consumption (2017-2022)

      • 10.3.5 France Famciclovir Consumption (2017-2022)

      • 10.3.6 Italy Famciclovir Consumption (2017-2022)

      • 10.3.7 Denmark Famciclovir Consumption (2017-2022)

      • 10.3.8 Finland Famciclovir Consumption (2017-2022)

      • 10.3.9 Norway Famciclovir Consumption (2017-2022)

      • 10.3.10 Sweden Famciclovir Consumption (2017-2022)

      • 10.3.11 Poland Famciclovir Consumption (2017-2022)

      • 10.3.12 Russia Famciclovir Consumption (2017-2022)

      • 10.3.13 Turkey Famciclovir Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Famciclovir Consumption (2017-2022)

      • 10.4.2 Japan Famciclovir Consumption (2017-2022)

      • 10.4.3 India Famciclovir Consumption (2017-2022)

      • 10.4.4 South Korea Famciclovir Consumption (2017-2022)

      • 10.4.5 Pakistan Famciclovir Consumption (2017-2022)

      • 10.4.6 Bangladesh Famciclovir Consumption (2017-2022)

      • 10.4.7 Indonesia Famciclovir Consumption (2017-2022)

      • 10.4.8 Thailand Famciclovir Consumption (2017-2022)

      • 10.4.9 Singapore Famciclovir Consumption (2017-2022)

      • 10.4.10 Malaysia Famciclovir Consumption (2017-2022)

      • 10.4.11 Philippines Famciclovir Consumption (2017-2022)

      • 10.4.12 Vietnam Famciclovir Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Famciclovir Consumption (2017-2022)

      • 10.5.2 Colombia Famciclovir Consumption (2017-2022)

      • 10.5.3 Chile Famciclovir Consumption (2017-2022)

      • 10.5.4 Argentina Famciclovir Consumption (2017-2022)

      • 10.5.5 Venezuela Famciclovir Consumption (2017-2022)

      • 10.5.6 Peru Famciclovir Consumption (2017-2022)

      • 10.5.7 Puerto Rico Famciclovir Consumption (2017-2022)

      • 10.5.8 Ecuador Famciclovir Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Famciclovir Consumption (2017-2022)

      • 10.6.2 Kuwait Famciclovir Consumption (2017-2022)

      • 10.6.3 Oman Famciclovir Consumption (2017-2022)

      • 10.6.4 Qatar Famciclovir Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Famciclovir Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Famciclovir Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Famciclovir Consumption (2017-2022)

      • 10.7.2 South Africa Famciclovir Consumption (2017-2022)

      • 10.7.3 Egypt Famciclovir Consumption (2017-2022)

      • 10.7.4 Algeria Famciclovir Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Famciclovir Consumption (2017-2022)

      • 10.8.2 New Zealand Famciclovir Consumption (2017-2022)

    11 Global Famciclovir Competitive Analysis

    • 11.1 Mylan

      • 11.1.1 Mylan Company Details

      • 11.1.2 Mylan Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Mylan Famciclovir Main Business and Markets Served

      • 11.1.4 Mylan Famciclovir Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Apotex

      • 11.2.1 Apotex Company Details

      • 11.2.2 Apotex Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Apotex Famciclovir Main Business and Markets Served

      • 11.2.4 Apotex Famciclovir Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 HETERO

      • 11.3.1 HETERO Company Details

      • 11.3.2 HETERO Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 HETERO Famciclovir Main Business and Markets Served

      • 11.3.4 HETERO Famciclovir Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Novartis

      • 11.4.1 Novartis Company Details

      • 11.4.2 Novartis Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Novartis Famciclovir Main Business and Markets Served

      • 11.4.4 Novartis Famciclovir Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Beijing Jialin Pharmaceutical

      • 11.5.1 Beijing Jialin Pharmaceutical Company Details

      • 11.5.2 Beijing Jialin Pharmaceutical Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Beijing Jialin Pharmaceutical Famciclovir Main Business and Markets Served

      • 11.5.4 Beijing Jialin Pharmaceutical Famciclovir Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Aurobindo Pharma

      • 11.6.1 Aurobindo Pharma Company Details

      • 11.6.2 Aurobindo Pharma Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Aurobindo Pharma Famciclovir Main Business and Markets Served

      • 11.6.4 Aurobindo Pharma Famciclovir Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Hainan choitec Pharmaceuticals

      • 11.7.1 Hainan choitec Pharmaceuticals Company Details

      • 11.7.2 Hainan choitec Pharmaceuticals Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Hainan choitec Pharmaceuticals Famciclovir Main Business and Markets Served

      • 11.7.4 Hainan choitec Pharmaceuticals Famciclovir Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Cipla

      • 11.8.1 Cipla Company Details

      • 11.8.2 Cipla Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Cipla Famciclovir Main Business and Markets Served

      • 11.8.4 Cipla Famciclovir Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Chengdu Diao Pharmaceutical Group

      • 11.9.1 Chengdu Diao Pharmaceutical Group Company Details

      • 11.9.2 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Chengdu Diao Pharmaceutical Group Famciclovir Main Business and Markets Served

      • 11.9.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Shandong Luoxin Pharmaceutical Group

      • 11.10.1 Shandong Luoxin Pharmaceutical Group Company Details

      • 11.10.2 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Shandong Luoxin Pharmaceutical Group Famciclovir Main Business and Markets Served

      • 11.10.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Hikma

      • 11.11.1 Hikma Company Details

      • 11.11.2 Hikma Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Hikma Famciclovir Main Business and Markets Served

      • 11.11.4 Hikma Famciclovir Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Teva

      • 11.12.1 Teva Company Details

      • 11.12.2 Teva Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Teva Famciclovir Main Business and Markets Served

      • 11.12.4 Teva Famciclovir Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Macleods Pharmaceuticals

      • 11.13.1 Macleods Pharmaceuticals Company Details

      • 11.13.2 Macleods Pharmaceuticals Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Macleods Pharmaceuticals Famciclovir Main Business and Markets Served

      • 11.13.4 Macleods Pharmaceuticals Famciclovir Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 HISUN

      • 11.14.1 HISUN Company Details

      • 11.14.2 HISUN Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 HISUN Famciclovir Main Business and Markets Served

      • 11.14.4 HISUN Famciclovir Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global Famciclovir Market Outlook by Types and Applications to 2028

    • 12.1 Global Famciclovir Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 125 mg Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global 250 mg Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global 500 mg Tablets Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Famciclovir Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Cold sores Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Genital herpes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Shingles Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Famciclovir Market Analysis and Outlook to 2028

    • 13.1 Global Famciclovir Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Famciclovir Consumption Forecast (2022-2028)

      • 13.2.2 Canada Famciclovir Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Famciclovir Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Famciclovir Consumption Forecast (2022-2028)

      • 13.3.2 UK Famciclovir Consumption Forecast (2022-2028)

      • 13.3.3 Spain Famciclovir Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Famciclovir Consumption Forecast (2022-2028)

      • 13.3.5 France Famciclovir Consumption Forecast (2022-2028)

      • 13.3.6 Italy Famciclovir Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Famciclovir Consumption Forecast (2022-2028)

      • 13.3.8 Finland Famciclovir Consumption Forecast (2022-2028)

      • 13.3.9 Norway Famciclovir Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Famciclovir Consumption Forecast (2022-2028)

      • 13.3.11 Poland Famciclovir Consumption Forecast (2022-2028)

      • 13.3.12 Russia Famciclovir Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Famciclovir Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Famciclovir Consumption Forecast (2022-2028)

      • 13.4.2 Japan Famciclovir Consumption Forecast (2022-2028)

      • 13.4.3 India Famciclovir Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Famciclovir Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Famciclovir Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Famciclovir Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Famciclovir Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Famciclovir Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Famciclovir Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Famciclovir Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Famciclovir Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Famciclovir Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Famciclovir Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Famciclovir Consumption Forecast (2022-2028)

      • 13.5.3 Chile Famciclovir Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Famciclovir Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Famciclovir Consumption Forecast (2022-2028)

      • 13.5.6 Peru Famciclovir Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Famciclovir Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Famciclovir Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Famciclovir Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Famciclovir Consumption Forecast (2022-2028)

      • 13.6.3 Oman Famciclovir Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Famciclovir Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Famciclovir Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Famciclovir Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Famciclovir Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Famciclovir Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Famciclovir Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Famciclovir Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Famciclovir Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Famciclovir Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Famciclovir

    • Figure of Famciclovir Picture

    • Table Global Famciclovir Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Famciclovir Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 125 mg Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global 250 mg Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global 500 mg Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Cold sores Consumption and Growth Rate (2017-2022)

    • Figure Global Genital herpes Consumption and Growth Rate (2017-2022)

    • Figure Global Shingles Consumption and Growth Rate (2017-2022)

    • Figure Global Famciclovir Consumption by Country (2017-2022)

    • Table North America Famciclovir Consumption by Country (2017-2022)

    • Figure United States Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Canada Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Mexico Famciclovir Consumption and Growth Rate (2017-2022)

    • Table Europe Famciclovir Consumption by Country (2017-2022)

    • Figure Germany Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure UK Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Spain Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Belgium Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure France Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Italy Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Denmark Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Finland Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Norway Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Sweden Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Poland Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Russia Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Turkey Famciclovir Consumption and Growth Rate (2017-2022)

    • Table APAC Famciclovir Consumption by Country (2017-2022)

    • Figure China Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Japan Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure India Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure South Korea Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Thailand Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Singapore Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Philippines Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Famciclovir Consumption and Growth Rate (2017-2022)

    • Table South America Famciclovir Consumption by Country (2017-2022)

    • Figure Brazil Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Colombia Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Chile Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Argentina Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Peru Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Famciclovir Consumption and Growth Rate (2017-2022)

    • Table GCC Famciclovir Consumption by Country (2017-2022)

    • Figure Bahrain Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Oman Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Qatar Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Famciclovir Consumption and Growth Rate (2017-2022)

    • Table Africa Famciclovir Consumption by Country (2017-2022)

    • Figure Nigeria Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure South Africa Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Egypt Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Algeria Famciclovir Consumption and Growth Rate (2017-2022)

    • Table Oceania Famciclovir Consumption by Country (2017-2022)

    • Figure Australia Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Famciclovir Consumption and Growth Rate (2017-2022)

    • Table Mylan Company Details

    • Table Mylan Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Famciclovir Main Business and Markets Served

    • Table Mylan Famciclovir Product Portfolio

    • Table Apotex Company Details

    • Table Apotex Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Famciclovir Main Business and Markets Served

    • Table Apotex Famciclovir Product Portfolio

    • Table HETERO Company Details

    • Table HETERO Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table HETERO Famciclovir Main Business and Markets Served

    • Table HETERO Famciclovir Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Famciclovir Main Business and Markets Served

    • Table Novartis Famciclovir Product Portfolio

    • Table Beijing Jialin Pharmaceutical Company Details

    • Table Beijing Jialin Pharmaceutical Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Jialin Pharmaceutical Famciclovir Main Business and Markets Served

    • Table Beijing Jialin Pharmaceutical Famciclovir Product Portfolio

    • Table Aurobindo Pharma Company Details

    • Table Aurobindo Pharma Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma Famciclovir Main Business and Markets Served

    • Table Aurobindo Pharma Famciclovir Product Portfolio

    • Table Hainan choitec Pharmaceuticals Company Details

    • Table Hainan choitec Pharmaceuticals Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hainan choitec Pharmaceuticals Famciclovir Main Business and Markets Served

    • Table Hainan choitec Pharmaceuticals Famciclovir Product Portfolio

    • Table Cipla Company Details

    • Table Cipla Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Famciclovir Main Business and Markets Served

    • Table Cipla Famciclovir Product Portfolio

    • Table Chengdu Diao Pharmaceutical Group Company Details

    • Table Chengdu Diao Pharmaceutical Group Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chengdu Diao Pharmaceutical Group Famciclovir Main Business and Markets Served

    • Table Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio

    • Table Shandong Luoxin Pharmaceutical Group Company Details

    • Table Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shandong Luoxin Pharmaceutical Group Famciclovir Main Business and Markets Served

    • Table Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio

    • Table Hikma Company Details

    • Table Hikma Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hikma Famciclovir Main Business and Markets Served

    • Table Hikma Famciclovir Product Portfolio

    • Table Teva Company Details

    • Table Teva Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Famciclovir Main Business and Markets Served

    • Table Teva Famciclovir Product Portfolio

    • Table Macleods Pharmaceuticals Company Details

    • Table Macleods Pharmaceuticals Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table Macleods Pharmaceuticals Famciclovir Main Business and Markets Served

    • Table Macleods Pharmaceuticals Famciclovir Product Portfolio

    • Table HISUN Company Details

    • Table HISUN Famciclovir Sales, Price, Value and Gross Profit (2017-2022)

    • Table HISUN Famciclovir Main Business and Markets Served

    • Table HISUN Famciclovir Product Portfolio

    • Figure Global 125 mg Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 250 mg Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 500 mg Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cold sores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genital herpes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Shingles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Famciclovir Consumption Forecast by Country (2022-2028)

    • Table North America Famciclovir Consumption Forecast by Country (2022-2028)

    • Figure United States Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Famciclovir Consumption Forecast by Country (2022-2028)

    • Figure Germany Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Famciclovir Consumption Forecast by Country (2022-2028)

    • Figure China Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Famciclovir Consumption Forecast by Country (2022-2028)

    • Figure Brazil Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Famciclovir Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Famciclovir Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Famciclovir Consumption Forecast by Country (2022-2028)

    • Figure Australia Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Famciclovir Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.